发明名称 ENZYMATIC NEUTRALIZATION OF HEPARIN
摘要 <p>A heparinase derived from Flavobacterium heparinum which meets all requirements for a clinical reagent that can eliminate heparin interference of normal blood function has been developed. The heparinase, derived from Flavobacterium heparinum, is free of a component that inhibits coagulation wherein the anticoagulant component does not bind, and the heparinase does bind, to a polysulfated resin having a pH of 7.0 and a conductivity between 3 and 12 mmhos. It is stable under normal manufacturing, shipping and clinical storage conditions for at least one year. The heparinase in useful in vitro to eliminate the interference in hematological assays due to the presence of heparin. The heparinase is also useful for the in vivo neutralization of heparin during surgical procedures. Advantages of this enzyme are that it achieves neutralization faster and more completely than previously available enzymes and is stable for long periods of time.</p>
申请公布号 EP0537325(B1) 申请公布日期 1999.11.03
申请号 EP19920910865 申请日期 1992.04.03
申请人 IBEX TECHNOLOGIES 发明人 ZIMMERMANN, JOSEPH, J.;LEWIS, N., TRACEY;HEFT, ROBERT, A.
分类号 A61K38/46;A61K35/14;A61K38/51;A61P7/04;C12N9/24;C12N9/88;C12Q1/34;C12Q1/527;C12Q1/56;C12R1/20;(IPC1-7):A61K38/51;G01N33/86 主分类号 A61K38/46
代理机构 代理人
主权项
地址